113 related articles for article (PubMed ID: 3786765)
1. Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system.
Saini S; Stark DD; Hahn PF; Wittenberg J; Brady TJ; Ferrucci JT
Radiology; 1987 Jan; 162(1 Pt 1):211-6. PubMed ID: 3786765
[TBL] [Abstract][Full Text] [Related]
2. Ferrite particles: a superparamagnetic MR contrast agent for enhanced detection of liver carcinoma.
Saini S; Stark DD; Hahn PF; Bousquet JC; Introcasso J; Wittenberg J; Brady TJ; Ferrucci JT
Radiology; 1987 Jan; 162(1 Pt 1):217-22. PubMed ID: 3786766
[TBL] [Abstract][Full Text] [Related]
3. MR imaging of splenic metastases: ferrite-enhanced detection in rats.
Weissleder R; Hahn PF; Stark DD; Rummeny E; Saini S; Wittenberg J; Ferrucci JT
AJR Am J Roentgenol; 1987 Oct; 149(4):723-6. PubMed ID: 3498320
[TBL] [Abstract][Full Text] [Related]
4. Ferrite particles: a new magnetic resonance imaging contrast agent. Lack of acute or chronic hepatotoxicity after intravenous administration.
Bacon BR; Stark DD; Park CH; Saini S; Groman EV; Hahn PF; Compton CC; Ferrucci JT
J Lab Clin Med; 1987 Aug; 110(2):164-71. PubMed ID: 3598345
[TBL] [Abstract][Full Text] [Related]
5. Ferrite particles for bowel contrast in MR imaging: design issues and feasibility studies.
Hahn PF; Stark DD; Saini S; Lewis JM; Wittenberg J; Ferrucci JT
Radiology; 1987 Jul; 164(1):37-41. PubMed ID: 3588924
[TBL] [Abstract][Full Text] [Related]
6. Ferrite-enhanced MR imaging of hepatic lymphoma: an experimental study in rats.
Weissleder R; Stark DD; Compton CC; Wittenberg J; Ferrucci JT
AJR Am J Roentgenol; 1987 Dec; 149(6):1161-5. PubMed ID: 3318339
[TBL] [Abstract][Full Text] [Related]
7. Splenic lymphoma: ferrite-enhanced MR imaging in rats.
Weissleder R; Stark DD; Rummeny EJ; Compton CC; Ferrucci JT
Radiology; 1988 Feb; 166(2):423-30. PubMed ID: 3336717
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of hepatocellular carcinomas from hyperplastic nodules induced in rat liver with ferrite-enhanced MR imaging.
Kawamori Y; Matsui O; Kadoya M; Yoshikawa J; Demachi H; Takashima T
Radiology; 1992 Apr; 183(1):65-72. PubMed ID: 1549696
[TBL] [Abstract][Full Text] [Related]
9. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver.
Stark DD; Weissleder R; Elizondo G; Hahn PF; Saini S; Todd LE; Wittenberg J; Ferrucci JT
Radiology; 1988 Aug; 168(2):297-301. PubMed ID: 3393649
[TBL] [Abstract][Full Text] [Related]
10. [Magnetic resonance tomography of focal liver and spleen lesions. Experiences using ferrite, a new RES-specific MR contrast medium].
Rummeny E; Weissleder R; Stark DD; Elizondo G; Ferrucci JT
Radiologe; 1988 Aug; 28(8):380-6. PubMed ID: 3174975
[TBL] [Abstract][Full Text] [Related]
11. Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T.
Marchal G; Van Hecke P; Demaerel P; Decrop E; Kennis C; Baert AL; van der Schueren E
AJR Am J Roentgenol; 1989 Apr; 152(4):771-5. PubMed ID: 2784260
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular MR imaging with iron oxide particles: utility of a superparamagnetic contrast agent and the role of diffusion in signal loss.
Rozenman Y; Zou XM; Kantor HL
Radiology; 1990 Jun; 175(3):655-9. PubMed ID: 2343109
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of MR relaxation effects of iron oxide particles in liver and spleen.
Majumdar S; Zoghbi S; Pope CF; Gore JC
Radiology; 1988 Dec; 169(3):653-8. PubMed ID: 3186986
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of a superparamagnetic iron oxide in MR imaging of chronic liver disease in an animal model.
Kreft B; Block W; Dombrowski F; Fackeldey A; Bachmann R; Mühlhäuser J; Träber F; Oksendal A; Pfeifer U; Schild HH
AJR Am J Roentgenol; 1998 Mar; 170(3):661-8. PubMed ID: 9490949
[TBL] [Abstract][Full Text] [Related]
15. Hepatic micrometastases in the rat: ferrite-enhanced MR imaging.
Tsang YM; Stark DD; Chen MC; Weissleder R; Wittenberg J; Ferrucci JT
Radiology; 1988 Apr; 167(1):21-4. PubMed ID: 3347724
[TBL] [Abstract][Full Text] [Related]
16. Paramagnetic macrocyclic complexes as contrast agents for MR imaging: proton nuclear relaxation rate enhancement in aqueous solution and in rat tissues.
Jackels SC; Kroos BR; Hinson WH; Karstaedt N; Moran PR
Radiology; 1986 May; 159(2):525-30. PubMed ID: 3961187
[TBL] [Abstract][Full Text] [Related]
17. In vivo MR tracking of mesenchymal stem cells in rat liver after intrasplenic transplantation.
Ju S; Teng GJ; Lu H; Zhang Y; Zhang A; Chen F; Ni Y
Radiology; 2007 Oct; 245(1):206-15. PubMed ID: 17717324
[TBL] [Abstract][Full Text] [Related]
18. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging.
Hahn PF; Stark DD; Lewis JM; Saini S; Elizondo G; Weissleder R; Fretz CJ; Ferrucci JT
Radiology; 1990 Jun; 175(3):695-700. PubMed ID: 2343116
[TBL] [Abstract][Full Text] [Related]
19. Ferrite particles as an MR contrast agent.
Saini S; Ferrucci JT
Radiology; 1988 Dec; 169(3):656. PubMed ID: 3186987
[No Abstract] [Full Text] [Related]
20. Pyogenic liver abscess: contrast-enhanced MR imaging in rats.
Weissleder R; Saini S; Stark DD; Elizondo G; Compton C; Wittenberg J; Ferrucci JT
AJR Am J Roentgenol; 1988 Jan; 150(1):115-20. PubMed ID: 3257107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
